Simplify Logo

Full-Time

Senior Accountant

Confirmed live in the last 24 hours

Element Biosciences

Element Biosciences

201-500 employees

Biotechnology firm specializing in DNA sequencing

Biotechnology

Compensation Overview

$104.6k - $137.4kAnnually

+ Stock Options + Bonus

Senior

San Diego, CA, USA

This role is based in San Diego.

Category
Financial Accounting
Financial Analysis
Payroll Accounting
Accounting
Required Skills
NetSuite
Excel/Numbers/Sheets
Requirements
  • Bachelors and/or Masters degree in Accounting, Finance or a related discipline with a minimum of 5+ years of broad, progressive accounting experience.
  • A CPA designation is preferred but not required.
  • Experience with the preparation of financial statements in a multi-entity, multi-currency environment preferred.
  • NetSuite proficiency preferred.
  • Proficiency with MS Excel, Word, and PowerPoint.
  • Excellent communications and interpersonal skills with the ability to effectively engage with both internal and external stakeholders.
  • A passion for teamwork and continuous improvement.
Responsibilities
  • Prepare and/or review monthly journal entries and account reconciliations.
  • Assist with the preparation of monthly, quarterly, and annual financial statements.
  • Support the establishment and enhancement of a strong internal control environment.
  • Own the accounting process over key areas such as cash, fixed assets, leasing, and intercompany.
  • Effectively interact with Human Resources and third-party providers to ensure the proper accounting for payroll and employee benefits.
  • Support and/or perform the processing of certain tax filings.
  • Identify, provide input to and/or support improvements to systems and processes to drive efficiency and enhance effectiveness.

Element Biosciences specializes in next-generation sequencing (NGS) technology, primarily through its product, the AVITI System. This compact benchtop system provides high-quality DNA sequencing at a low cost, charging only $1 per million reads, which is significantly less than the industry average. The AVITI System is designed to deliver industry-leading accuracy, allowing users, including academic researchers and pharmaceutical companies, to maximize their resources. Element Biosciences differentiates itself from competitors by forming partnerships with other biotech firms, such as QIAGEN, to offer complete NGS workflows, enhancing the value of their product. Additionally, the company runs the 2023 AVITI for All Grant program, which provides free sequencing services for various applications, promoting research and demonstrating the capabilities of the AVITI System. The goal of Element Biosciences is to make high-quality sequencing accessible and affordable for a wide range of users.

Company Stage

Series C

Total Funding

$414M

Headquarters

San Diego, California

Founded

2017

Growth & Insights
Headcount

6 month growth

6%

1 year growth

10%

2 year growth

24%
Simplify Jobs

Simplify's Take

What believers are saying

  • Element Biosciences' recent $277M Series D funding round underscores strong investor confidence and provides substantial resources for growth and innovation.
  • The rapid growth in AVITI System installations, from 20 to over 150 units in a year, indicates strong market adoption and customer satisfaction.
  • The introduction of AVITI24 and Trinity platforms positions Element Biosciences at the forefront of multi-omics and targeted sequencing, potentially revolutionizing research capabilities.

What critics are saying

  • The competitive landscape in NGS technology is intense, with established players potentially overshadowing Element Biosciences' market presence.
  • Rapid expansion and scaling may strain operational capabilities and affect product quality or customer support.

What makes Element Biosciences unique

  • Element Biosciences offers the AVITI System, which provides high-quality sequencing at a significantly lower cost than industry standards, making advanced sequencing more accessible.
  • Strategic partnerships with companies like QIAGEN and Twist Bioscience enhance the AVITI System's capabilities, offering comprehensive NGS workflows and exome sequencing solutions.
  • The company's grant program, AVITI for All, democratizes access to sequencing technology, showcasing the system's capabilities and fostering innovation across various fields.

Benefits

100% company-paid medical, dental, & vision coverage

Flexible spending & health savings accounts

Premier mental health care

401(k) with immediately vested 4% company match

Company-paid Life and AD&D insurance

Stock option grants

Flexible time off

10 paid annual holidays

8-weeks paid parental leave